Evicenter
MarkdownMedical informationP&T meetings
Cretostimogene grenadenorepvec (CG0070)

BCG-unresponsive high-risk non-muscle-invasive bladder cancer

Manufacturer
CG Oncology
Launch
Not announced
Last updated
161 sources

Product information and disease descriptionPlace of product in therapyDisease descriptionEpidemiology

Prevalence of BCG-unresponsive high-risk non-muscle-invasive bladder cancer

4 evidence topics · 6 sources